**Core Concept**
Radioiodine is a key treatment modality for certain types of thyroid cancer, particularly papillary carcinomas. The mechanism of action involves the uptake of radioactive iodine by neoplastic thyroid cells, which can then undergo cell death due to radiation damage.

**Why the Correct Answer is Right**
The correct answer is that radioiodine destroys neoplastic cells by inducing DNA damage and apoptosis through the formation of free radicals. This is made possible by the presence of the sodium-iodide symporter (NIS) on the surface of thyroid cells, which allows them to take up iodine from the bloodstream. Once inside the cell, the radioactive iodine can be oxidized and form free radicals, which then damage the DNA and trigger cell death.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because while radioiodine does cause DNA damage, it is not the primary mechanism of cell death in this context. The correct answer highlights the role of free radicals in inducing apoptosis.
**Option B:** This option is incorrect because while thyroid hormone analogs can affect thyroid cell growth, they are not the primary mechanism of action for radioiodine in treating papillary carcinomas.
**Option C:** This option is incorrect because while radiation therapy can cause DNA damage, the specific mechanism of action for radioiodine in treating papillary carcinomas involves the formation of free radicals, not direct DNA damage.

**Clinical Pearl / High-Yield Fact**
It's essential to note that the effectiveness of radioiodine therapy in treating papillary carcinomas is dependent on the presence of the sodium-iodide symporter (NIS) on the surface of the neoplastic cells. This highlights the importance of understanding the molecular mechanisms underlying thyroid cancer treatment.

**Correct Answer: B. Ionizing radiation from free radical formation.**